Marlex FDA Monday, October 19, 1981 0.00 Neutral

FDA Approves FUROSEMIDE — Marlex Pharmaceuticals, Inc.

The FDA has confirmed the approval of Marlex Pharmaceuticals' oral furosemide product, supporting a staple in acute treatment protocols. While not a novel molecule, broadening the commercial availability creates a competitive ripple effect in the generic diuretic space.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day